LWCL (LWCL) Stock Price & Analysis
LWCL (LWCL) rose 0.00% to USD 6.25 as of June 10, 2026 at 02:19 UTC, according to Nexqual real-time market data.
LWCL last closed at USD 6.25; the session ranged USD 6.5–6.5 on volume of 100 shares. Market capitalization is $6.64M, with a 52-week range of USD 6.02–43.5 (PNK). Source: Nexqual, June 10, 2026 at 02:19 UTC.
Key Statistics (as of June 10, 2026 at 02:19 UTC)
| Price | USD 6.25 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 6.25 |
| Open | USD 6.5 |
| Day Range | USD 6.5 – 6.5 |
| 52-Week Range | USD 6.02 – 43.5 |
| Volume | 100 shares |
| Market Cap | $6.64M |
| Exchange | PNK |
Technical Analysis (LWCL)
Nexqual's technical model rates LWCL "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 02:19 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 6.36) |
| MACD | -0.09 (negative) |
Analyst Ratings (LWCL)
Wall Street analysts rate LWCL "None", per Nexqual as of June 10, 2026 at 02:19 UTC.
| Consensus Rating | None |
|---|
Earnings (LWCL)
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Financials & Fundamentals (LWCL)
| Total Revenue | $7.05M |
|---|---|
| Revenue Growth (YoY) | -14.60% |
| Gross Margin | +0.00% |
| Operating Margin | +7.90% |
| Profit Margin | -35.69% |
| ROE | -8.21% |
| Total Cash | $69.75M |
| Total Debt | $86.96M |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Financial Health Score (LWCL)
Nexqual rates LWCL's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:19 UTC.
| Growth | Critical — Revenue -15% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $70M cash vs $87M debt |
| Cash Flow | Mixed — No data |
| Efficiency | Critical — ROE -8%, ROA -0.7% |
Ownership (LWCL)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +1.06% |
| Shares Outstanding | 1.06M |
| Float | 921,267 |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Major Backers & Investors (LWCL)
Notable institutional backers of LWCL include Ferguson Wellman Capital Management, Inc., according to Nexqual as of June 10, 2026 at 02:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Ferguson Wellman Capital Management, Inc. | 1.05% |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NMTRQ | 9 Meters Biopharma, Inc. | USD 0 | ▲ 0% |
| RAFI | Regency Affiliates, Inc. | USD 4.18 | ▲ 0% |
| TBBA | TEB Bancorp Inc. | USD 6.5 | ▼ 0.31% |
| GMVDF | G Medical Innovations Holdings | USD 0 | ▲ 0% |
| FOTB | First Ottawa Bancshares | USD 218.75 | ▼ 1.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:19 UTC. This page is informational and not investment advice.